首页> 外文期刊>Archives of Internal Medicine >Incidence and Prognostic Significance of Thrombocytopenia in Patients Receiving Heparin Therapy
【24h】

Incidence and Prognostic Significance of Thrombocytopenia in Patients Receiving Heparin Therapy

机译:发病和预后的意义血小板减少的患者接受肝素治疗

获取原文
获取原文并翻译 | 示例
           

摘要

I read the recent article by Oliveira et al with interest. There are a few questions in my mind. First, the authors rely on automated platelet counts but ignore peripheral blood smear. This would lead to the inclusion of pseudothrombocytopenia, a condition of platelet clumping associated with blood collected in EDTA tubes. Second, a significant proportion of the enrolled patients are elderly with premorbid conditions.l Some of them are likely to receive several medications. While their exclusion criteria include only those receiving antineoplastic agents known to affect bone marrow, concomitant use of potential inducers of thrombocytopenia, including antimicrobials, analgesics, anticonvulsants, and thiazide diuretics, might contribute to the reported thrombocytopenia.
机译:最近我读了篇文章,奥利维拉et al的兴趣。首先,作者依靠自动化的血小板但忽视外周血涂片。会导致的吗pseudothrombocytopenia,血小板的一个条件凝结与EDTA的血液收集有关管。登记病人与发病前的老人条件。一些药物。只包括那些接受标准抗肿瘤的药物会影响骨骨髓,伴随的潜在诱发的使用血小板减少症,包括抗菌素,止痛药、抗惊厥药物和噻嗪类利尿剂,会导致报道血小板减少症。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号